Lipiński Patryk, Ciara Elżbieta, Jurkiewicz Dorota, Mekrouda Magda, Cielecka-Kuszyk Joanna, Jurkiewicz Elżbieta, Płoski Rafał, Pawłowska Joanna, Jankowska Irena
Department of Pediatrics, Nutrition and Metabolic Diseases, The Children's Memorial Health Institute, 04-730 Warsaw, Poland.
Department of Medical Genetics, The Children's Memorial Health Institute, 04-736 Warsaw, Poland.
Diagnostics (Basel). 2023 May 30;13(11):1917. doi: 10.3390/diagnostics13111917.
The increasing usage of NGS technology has enabled the discovery of new causal genes in ciliopathies, including the gene. The aim of our study was to present the clinical, pathological and molecular report of six patients (from three unrelated families) with biallelic pathogenic variants. A detailed overview of the reported patients with -related disease was provided.
A retrospective chart review of the clinical, biochemical, pathological (liver histology) and molecular features of the study group was performed. The database PubMed (MEDLINE) was searched for relevant studies.
All the patients presented with cholestatic jaundice and elevated GGT; the mean age was 2 months. The initial liver biopsy was performed in four children at a mean age of 3 months (age range: 2-5 months). In all of them, features of cholestasis, portal fibrosis and mild portal inflammation were observed; in three of them ductular proliferation was observed. One patient had undergone liver transplantation (LTx) at 8 years of age. At hepatectomy, a biliary-pattern cirrhosis was observed. Only one patient presented with features of renal disease. Whole exome sequencing was performed in all patients at the last follow-up visit (mean age 10 years). Three different variants (one novel) in the gene were identified in the study group. With our six patients, a total of 34 patients with -related hepatic ciliopathy were identified. The main clinical presentation of -related ciliopathy was liver disease in the form of neonatal sclerosing cholangitis. The predominance of early and severe liver disease associated with no or mildly expressed kidney involvement was observed.
Our findings expand the molecular spectrum of pathogenic variants, provide a more accurate picture of the phenotypic expression associated with molecular changes in this gene and confirm a loss of functional behaviour as the mechanism of disease.
二代测序(NGS)技术的使用日益增加,使得在纤毛病中发现了新的致病基因,包括[具体基因]。我们研究的目的是呈现6例(来自3个无亲缘关系的家庭)携带双等位基因致病变异患者的临床、病理和分子报告。提供了已报道的与[具体基因]相关疾病患者的详细概述。
对研究组的临床、生化、病理(肝脏组织学)和分子特征进行回顾性病历审查。在数据库PubMed(MEDLINE)中检索相关研究。
所有患者均表现为胆汁淤积性黄疸和γ-谷氨酰转移酶(GGT)升高;平均年龄为2个月。4名儿童在平均年龄3个月(年龄范围:2 - 5个月)时进行了首次肝脏活检。在所有这些患儿中,均观察到胆汁淤积、门脉纤维化和轻度门脉炎症的特征;其中3例观察到小胆管增生。1例患者在8岁时接受了肝移植(LTx)。在肝切除时,观察到胆管型肝硬化。只有1例患者表现出肾脏疾病的特征。在最后一次随访(平均年龄10岁)时,对所有患者进行了全外显子测序。在研究组中鉴定出该基因的3种不同变异(1种为新变异)。连同我们的6例患者,共鉴定出34例与[具体基因]相关的肝纤毛病患者。与[具体基因]相关的纤毛病的主要临床表现为新生儿硬化性胆管炎形式的肝脏疾病。观察到早期和严重肝脏疾病占主导,且无或仅有轻度表达的肾脏受累。
我们的研究结果扩展了致病[具体基因]变异的分子谱,提供了与该基因分子变化相关的表型表达更准确的情况,并证实功能丧失行为是疾病机制。